A multivariate analysis of prognostic factors related to recurrence and progression of superficial bladder cancer

Urologic Oncology

Volumn 2, Issue 5, 1996, Pages 152-157

  Saiki, Shigeru ^a   Kinouchi, Toshiaki ^a   Meguro, Norio ^a   Maeda, Osamu ^a   Kuroda, Masao ^a   Usami, Michiyuki ^a   Kotake, Toshihiko ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Multivariate analysis; progression; recurrence; superficial bladder cancer

Indexed keywords

ADULT; ARTICLE; BLADDER CANCER; CANCER CYTODIAGNOSIS; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SUPERFICIAL CANCER; URINE CYTOLOGY;

EID: 0030235879     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-1439(96)00094-4     Document Type: Article

References (19)

1. 1. Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD, Hawkins IR, for national bladder cancer collaborative group A. Superficial bladder cancer: Progression and recurrence. J Urol 1983;130:1083-1086.
2. 2. Flamm J, Havelec L. Factors affecting survival in primary superficial bladder cancer. Eur Urol 1990;17:113-118.
3. 3. Kiemeney LALA, Witjes JA, Heijbroek RP, Verbeek ALM, Debruyne FMJ. Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. J Urol 1993;150:60-64.
4. 4. Vet JAM, Debruyne FMJ, Schalken JA. Molecular prognostic factors in bladder cancer. Word J Urol 1994;12:84-88.
5. 5. Saiki S, Kinouchi T, Kuroda M, Uenaka A, Nakayama E, Kotake T. Characterization of mouse monoclonal antibody B1.4 reactive with human invasive bladder cancer and some other malignant tumors but not with normal urinary epithelium. Jpn J Cancer Res 1994;85:756-761.
6. 6. Kinouchi T, Saiki S, Naoe T, Uenaka A, Kotake T, Shiku H, Nakayama E. Correlation of c-myc expression with nuclear pleomorphism in human renal cell carcinoma. Cancer Res 1989;49:3627-3630.
7. 7. Aoyagi T, Bander NH. Cytotoxicity of gallium nitrate in vitro using bladder cancer cells. Int J Urol 1995;2:288-294.
8. 8. Japanese Urological Association, the Japanese Society of Pathology. General Rules for Clinical and Pathological Studies on Bladder Cancer (in Japanese). 2nd Ed., Kanehara Co., Ltd., Tokyo, 1993;80-81.
9. 9. Fradet Y, Tardif M, Boueget L, Robert J, the Laval University Urology Group: Clinical cancer progression in urinary bladder tumors evaluated by multiparameter flow cytometry with monoclonal antibodies. Cancer Res 1990;50:432-437.
10. 10. Neal DE, Sharples L, Smith K, Fennelly J, Hall RR, Harris AL. The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer 1990;65:1619-1625.
11. 11. Melon K, Wright C, Kelly P, Horne CHW, Neal DE. Bladder cancer, long-term outcome related to epidermal growth factor receptor status in bladder cancer. J Urol 1995;153:919-925.
12. 12. Sato K, Moriyama M, Mori S, Saito M, Watanuki T, Terada K, Okuhara E, Akiyama T, Toyoshima K, Yamamoto T, Kato T. An immunohistological evaluation of c-erbB-2 gene product in patients with urinary bladder carcinoma. Cancer 1992;70:2493-2498.
13. 13. Lipponen PK. Expression of c-erbB-2 oncoprotein in transitional cell bladder cancer. Eur J Cancer 1993;29A:749-753.
14. 14. Fujimoto K, Yamada Y, Okajima E, Kakizoe T, Sasaki H, Sugimura T, Terada M. Frequent association of p53 mutation in invasive bladder cancer. Cancer Res 1992;52:1393-1396.
15. 15. Sarkis AS, Dalbagni G, Cordon-Cardo C, Zhang ZF, Sheinfeld J, Fair WR, Herr HW, Reuter VE. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: A marker for disease progression. J Natl Cancer Inst 1993;85:53-59.
16. 16. Lipponen PK. Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value. Int J Cancer 1993;53:365-370.
17. 17. Logothetis CJ, Xu HJ, Ro JY, Hu SX, Sahin A, Ordonez N, Benedict WF. Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J Natl Cancer Inst 1992;84:1256-1261.
18. 18. Seymour GJ, Walsh MD, Lavin MF, Strutton G, Gardiner RA. Transferrin receptor expression by human bladder transitional cell carcinomas. Urol Res 1987;15:341-344.
19. 19. Smith NW, Strutton GM, Walsh MD, Wright GR, Seymour GJ, Lavin MF, Gardiner RA. Transferrin receptor expression in primary superficial human bladder tumors identifies patients who develop recurrences. Br J Urol 1990;65:339-344.